BIOTREDIN® IN PEDIATRIC PRACTICE

Download full text PDF
Issue: 
12
Year: 
2016

E. Sheshegova (1), Candidate of Pharmaceutical Sciences; E. Tyukina (1); Ya Nartsissov (1), Candidate of Physical and Mathematical Sciences; T. Potupchik (2), Candidate of Medical Sciences; O. Veselova (2), Candidate of Medical Sciences 1 -Research Institute of cytochemistry and molecular pharmacology, Moscow 2 -Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University

The paper gives the results of a clinical trial of Biotredin® used to treat children and adolescents (a total of 103 people) at the All-Russian Research Center for Hygiene and Prevention of Diseases in Children, Adolescents, and Young Adults, USSR Academy of Medical Sciences. Without causing autonomic reactions, the drug improved mood and self-confidence, increased short-term memory span, and positively affected attention and hemodynamic parameters in one-third of the examinees.
Keywords: 
psychotherapy
Biotredin®
adolescents
deviant behavior
memory
attention

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Baranov A.A., Kuchma V.R., Suhareva L.M. i dr. Otsenka nervno-psihicheskogo zdorov'ja i psihofiziologicheskogo statusa detej i podrostkov pri profilakticheskih meditsinskih osmotrah. Posobie dlja vrachej / M., 2005; 109.
  2. Gorina A.S., Kolesnichenko L.S. Aminokisloty syvorotki krovi i mochi u detej s sindromom Aspergera // Sib. med. zhurn. – 2011; 7: 69–73.
  3. Komissarova I.A., Jazdovskaja S.V. Tselesoobraznost' ispol'zovanija farmatsevticheskih preparatov Biotredina® i glitsina dlja profilaktiki rannej alkogolizatsii i narkotizatsii podrostkov. IV nats. kongress «Chelovek i lekarstvo», M., 1997; 63.
  4. Komissarova I.A., Jazdovskaja S.V. i dr. Primenenie Glitsina i Biotredina v pubertatnom vozraste. V Ross. nats. kongress «Chelovek i lekarstvo». M., 1998; 284.
  5. Malinovskij A.V. Javljaetsja li treonin nezamenimoj aminokislotoj dlja cheloveka? // Nauchnye obzory. – 2011; 41 (4): 116–9.
  6. Potupchik T.V., Veselova O.F., Evert L.S. i dr. Korrektsija kognitivnyh narushenij u detej s ispol'zovaniem nootropnyh preparatov // Obozrenie psihiat. i med. psihol. – 2015; 3: 109–13.
  7. Potupchik T.V., Veselova O.F., Evert L.S. Nootropnye preparaty pri narushenijah kognitivnyh funktsij u detej // Vrach. – 2016; 4: 75–8.
  8. Potupchik T.V., Evert L.S., Veselova O.F. i dr. Profilaktika i korrektsija narushenij adaptatsionno-prisposobitel'nyh protsessov u detej // Meditsinskaja sestra. – 2016; 3: 54–5.
  9. Potupchik T.V., Veselova O.F., Evert L.S. i dr. Spektr farmakologicheskih effektov glitsina // Vrach. – 2015; 12: 14–7.
  10. Primenenie metabolitnogo preparata Biotredin® dlja profilaktiki i lechenija narkologicheskih zabolevanij i funktsional'nyh narushenij u detej i podrostkov. Inform. pis'mo Komiteta zdravoohranenija Pravitel'stva Moskvy № 2218/287. M., 2000; 117–8.
  11. Rannie projavlenija psihicheskih zabolevanij u detej i podrostkov: metodicheskie rekomendatsii / Tjumen', 2010.
  12. Umarova H.Ja., Chugunov A.V., Kazakov A.Ju. Primenenie Biotredina v praktike nevrologa // Nevrol. i psihiatr. – 2014; 94 (6): 49–52.
  13. Filippova E.A. Rannjaja diagnostika nevroticheskih i patoharakterologicheskih rasstrojstv u shkol'nikov // Pediatrija. – 2011; 90 (2): 138–41.
  14. Jazdovskaja S.V., Komissarova I.A. i dr. Primenenie Biotredina® pri ambulatornom lechenii bol'nyh s razlichnymi formami patologii vlechenija. V Ross. nats. kongress «Chelovek i lekarstvo». M., 1998; 245.
  15. Jazdovskaja S.V., Pivovarova E.U. i dr. Primenenie Biotredina® dlja podavlenija vlechenija k narkoticheskim sredstvam. IV Ross. nats. kongress «Chelovek i lekarstvo». M., 1997; 149.
  16. Caram-Salas N., Reyes-Garcia G., Medina-Santillán R. et al. Thiamine and cyanocobalamin relieve neuropathic pain in rats: synergy with dexamethasone // Pharmacology. – 2006; 77 (2): 53–62.
  17. Cohen B. GABA-transaminase, the liver and infantile autism // Med. Hypotheses. – 2001; 57 (6): 673–4.
  18. Connors S., Crowell D. Secretin and autism: the role of cysteine // J. Am. Acad. Child Adolesc. Psychiatry. – 1999; 38 (7): 795–6.
  19. Kaáuzna-Czaplinska J., Michalska M., Rynkowski J. Determination of tryptophan in urine of autistic and healthy children by gas chromatography/mass spectrometry // Med. Sci. Monit. – 2010; 16 (10): 488–92.
  20. Kuwabara S., Nakazawa R., Azuma N. et al. Intravenous methylcobalamin treatment for uremic and diabetic neuropathy in chronic hemodialysis patients // Intern. Med. – 1999; 38 (6): 472–5.
  21. Takei N., Nawa H. mTOR signaling and its roles in normal and abnormal brain development // Front. Mol. Neurosci. – 2014; 7: 28–33.
  22. Yao J., Sun J., Zhao Q. et al. Neuregulin-1/ErbB4 signaling regulates Kv4.2-mediated transient outward K+ current through the Akt/mTOR pathway // Am. J. Physiol. Cell Physiol. – 2013; 305 (2): 197–206.
  23. Opisanie preparata Biotredin® (Biotredin). Entsiklopedija RLS: instruktsija po primeneniju i sostav, otzyvy, protivopokazanija. http://www.rlsnet.ru/tn_index_id_5778.htm